| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 48.254 | 22.142 | 25.983 | 32.242 | 34.685 | 58.009 | 45.438 | 35.116 | - | 25.456 |
| Total Income - EUR | 48.254 | 22.142 | 25.990 | 32.174 | 34.445 | 58.986 | 45.438 | 35.116 | - | 25.456 |
| Total Expenses - EUR | 49.262 | 27.181 | 28.965 | 34.793 | 31.493 | 55.651 | 44.961 | 33.280 | - | 23.697 |
| Gross Profit/Loss - EUR | -1.008 | -5.039 | -2.975 | -2.620 | 2.952 | 3.334 | 477 | 1.836 | - | 1.758 |
| Net Profit/Loss - EUR | -2.455 | -5.260 | -3.239 | -2.918 | 1.985 | 2.778 | 23 | 1.484 | - | 1.482 |
| Employees | 2 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | - | 0 |
Check the financial reports for the company - Admirmed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 |
| Current Assets | 70.823 | 70.649 | 78.019 | 81.174 | 87.244 | 70.023 | 60.338 | 56.684 | - | 49.683 |
| Inventories | 53.790 | 66.853 | 75.835 | 78.137 | 82.577 | 64.080 | 58.504 | 54.681 | - | 43.891 |
| Receivables | 899 | 907 | 851 | 1.049 | 176 | 833 | 815 | 881 | - | 1.938 |
| Cash | 16.134 | 2.889 | 1.333 | 1.988 | 4.491 | 5.110 | 1.019 | 1.122 | - | 3.854 |
| Shareholders Funds | -110.960 | -115.088 | -116.380 | -117.162 | -112.909 | -107.985 | -105.567 | -104.410 | - | -103.000 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | - | 40 |
| Debts | 181.783 | 185.738 | 194.399 | 198.336 | 200.153 | 178.008 | 165.905 | 161.094 | - | 152.683 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5630 - 5630" | |||||||||
| CAEN Financial Year |
5630
|
|||||||||
Comments - Admirmed Srl